These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31144444)

  • 1. Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
    Packer M
    Diabetes Obes Metab; 2019 Aug; 21(8):1765-1768. PubMed ID: 31144444
    [No Abstract]   [Full Text] [Related]  

  • 2. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.
    Park TS; Goldberg IJ
    Heart Fail Clin; 2012 Oct; 8(4):633-41. PubMed ID: 22999245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus and the Heart.
    Schütt K; Müller-Wieland D; Marx N
    Exp Clin Endocrinol Diabetes; 2019 Dec; 127(S 01):S102-S104. PubMed ID: 31860930
    [No Abstract]   [Full Text] [Related]  

  • 6. The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?
    Packer M
    Circulation; 2018 May; 137(19):2068-2073. PubMed ID: 29735591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in diabetes.
    Jankauskas SS; Kansakar U; Varzideh F; Wilson S; Mone P; Lombardi A; Gambardella J; Santulli G
    Metabolism; 2021 Dec; 125():154910. PubMed ID: 34627874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: The Role of Ceramides in Diabetes and Cardiovascular Disease.
    Summers SA
    Front Endocrinol (Lausanne); 2021; 12():667885. PubMed ID: 33776946
    [No Abstract]   [Full Text] [Related]  

  • 11. Voltage dependence of the Ca
    Al Kury L; Sydorenko V; Smail MMA; Qureshi MA; Shmygol A; Oz M; Singh J; Howarth FC
    Mol Cell Biochem; 2018 Sep; 446(1-2):25-33. PubMed ID: 29318456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.
    Sattar N; McGuire DK
    Circulation; 2018 Jul; 138(1):7-9. PubMed ID: 29967228
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of myocardial matrix expansion with cardiac magnetic resonance: entering a new area of cardiac risk stratification in type 2 diabetes mellitus?
    Schindler TH; Lima JA
    Eur Heart J; 2014 Mar; 35(10):608-11. PubMed ID: 24096323
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Appearance of Myocardial Fibrosis in Restrictive Diabetic Cardiomyopathy.
    Paulus WJ
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):554-556. PubMed ID: 37431656
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential impact of genetic variants in Nrf2 regulated antioxidant genes and risk prediction of diabetes and associated cardiac complications.
    Ramprasath T; Selvam GS
    Curr Med Chem; 2013; 20(37):4680-93. PubMed ID: 23834171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure in chronic Chagas' myocarditis. Analysis of 174 cases with 16 necropsies].
    Capris TA; Fernandez Moores AJ; Barcat JA
    Medicina (B Aires); 1969; 29(5):339-45. PubMed ID: 5000217
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.
    Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
    Cardiovasc Pathol; 2014; 23(1):17-20. PubMed ID: 23928368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
    Packer M
    Diabetes Obes Metab; 2018 Jun; 20(6):1361-1366. PubMed ID: 29359851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in the development of diabetic cardiomyopathy.
    Pepin ME; Wende AR
    Epigenomics; 2019 Apr; 11(5):469-472. PubMed ID: 30895816
    [No Abstract]   [Full Text] [Related]  

  • 20. A 64-year-old patient with heart failure and 'chronic liver disease': looking at the liver, the myocardium or the pericardium?
    Sampaio F; Fontes-Carvalho R
    Eur Heart J; 2014 Mar; 35(10):611. PubMed ID: 23713081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.